91ÖĆƬł§

Published on Market Research Reports® Inc. ()

Home > Global Aptamers Market Growth 2025-2031

Global Aptamers Market Growth 2025-2031

Publication ID: 
LPI01250719
Publication Date: 
January 17, 2025
Pages: 
123
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

The global Aptamers market size is predicted to grow from US$ 334 million in 2025 to US$ 985 million in 2031; it is expected to grow at a CAGR of 19.7% from 2025 to 2031.
Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called “Systematic evolution of ligands by exponential enrichment” (SELEX).
Aptamers receive their name from the Latin word aptus meaning “fit”. This means they bind to the target molecules with high specificity and high affinity.
Aptamers are short nucleic acids that interact with a variety of targets with high affinity and specificity. They have been shown to inhibit biological functions of cognate target proteins, and they are identifiable by an in vitro selection process, also termed SELEX (Systematic Evolution of Ligands by EXponential enrichment). Being nucleic acids, aptamers can be synthesized chemically or enzymatically.
Global Aptamers key players include TriLink BioTechnologies, SomaLogic, AM Biotechnologies, Aptamer Sciences, Base Pair Biotechnologies etc. The Global top 10 manufacturers hold a share about 14%.North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 30% and 22%.
The “Aptamers Industry Forecast” looks at past sales and reviews total world Aptamers sales in 2024, providing a comprehensive analysis by region and market sector of projected Aptamers sales for 2025 through 2031. With Aptamers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aptamers industry.
This Insight Report provides a comprehensive analysis of the global Aptamers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aptamers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aptamers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aptamers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aptamers.
This report presents a comprehensive overview, market shares, and growth opportunities of Aptamers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DNA-Based Aptamers
RNA-Based Aptamers
Segmentation by Application:
Research and Development
Drug Discovery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aptamers market?
What factors are driving Aptamers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aptamers market opportunities vary by end market size?
How does Aptamers break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aptamers Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aptamers by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aptamers by Country/Region, 2020, 2024 & 2031
2.2 Aptamers Segment by Type
2.2.1 DNA-Based Aptamers
2.2.2 RNA-Based Aptamers
2.3 Aptamers Sales by Type
2.3.1 Global Aptamers Sales Market Share by Type (2020-2025)
2.3.2 Global Aptamers Revenue and Market Share by Type (2020-2025)
2.3.3 Global Aptamers Sale Price by Type (2020-2025)
2.4 Aptamers Segment by Application
2.4.1 Research and Development
2.4.2 Drug Discovery
2.5 Aptamers Sales by Application
2.5.1 Global Aptamers Sale Market Share by Application (2020-2025)
2.5.2 Global Aptamers Revenue and Market Share by Application (2020-2025)
2.5.3 Global Aptamers Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Aptamers Breakdown Data by Company
3.1.1 Global Aptamers Annual Sales by Company (2020-2025)
3.1.2 Global Aptamers Sales Market Share by Company (2020-2025)
3.2 Global Aptamers Annual Revenue by Company (2020-2025)
3.2.1 Global Aptamers Revenue by Company (2020-2025)
3.2.2 Global Aptamers Revenue Market Share by Company (2020-2025)
3.3 Global Aptamers Sale Price by Company
3.4 Key Manufacturers Aptamers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aptamers Product Location Distribution
3.4.2 Players Aptamers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Aptamers by Geographic Region
4.1 World Historic Aptamers Market Size by Geographic Region (2020-2025)
4.1.1 Global Aptamers Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aptamers Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aptamers Market Size by Country/Region (2020-2025)
4.2.1 Global Aptamers Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aptamers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aptamers Sales Growth
4.4 APAC Aptamers Sales Growth
4.5 Europe Aptamers Sales Growth
4.6 Middle East & Africa Aptamers Sales Growth
5 Americas
5.1 Americas Aptamers Sales by Country
5.1.1 Americas Aptamers Sales by Country (2020-2025)
5.1.2 Americas Aptamers Revenue by Country (2020-2025)
5.2 Americas Aptamers Sales by Type (2020-2025)
5.3 Americas Aptamers Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aptamers Sales by Region
6.1.1 APAC Aptamers Sales by Region (2020-2025)
6.1.2 APAC Aptamers Revenue by Region (2020-2025)
6.2 APAC Aptamers Sales by Type (2020-2025)
6.3 APAC Aptamers Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aptamers by Country
7.1.1 Europe Aptamers Sales by Country (2020-2025)
7.1.2 Europe Aptamers Revenue by Country (2020-2025)
7.2 Europe Aptamers Sales by Type (2020-2025)
7.3 Europe Aptamers Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aptamers by Country
8.1.1 Middle East & Africa Aptamers Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aptamers Revenue by Country (2020-2025)
8.2 Middle East & Africa Aptamers Sales by Type (2020-2025)
8.3 Middle East & Africa Aptamers Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aptamers
10.3 Manufacturing Process Analysis of Aptamers
10.4 Industry Chain Structure of Aptamers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aptamers Distributors
11.3 Aptamers Customer
12 World Forecast Review for Aptamers by Geographic Region
12.1 Global Aptamers Market Size Forecast by Region
12.1.1 Global Aptamers Forecast by Region (2026-2031)
12.1.2 Global Aptamers Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aptamers Forecast by Type (2026-2031)
12.7 Global Aptamers Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 TriLink BioTechnologies
13.1.1 TriLink BioTechnologies Company Information
13.1.2 TriLink BioTechnologies Aptamers Product Portfolios and Specifications
13.1.3 TriLink BioTechnologies Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 TriLink BioTechnologies Main Business Overview
13.1.5 TriLink BioTechnologies Latest Developments
13.2 AptaBharat
13.2.1 AptaBharat Company Information
13.2.2 AptaBharat Aptamers Product Portfolios and Specifications
13.2.3 AptaBharat Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AptaBharat Main Business Overview
13.2.5 AptaBharat Latest Developments
13.3 SomaLogic
13.3.1 SomaLogic Company Information
13.3.2 SomaLogic Aptamers Product Portfolios and Specifications
13.3.3 SomaLogic Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 SomaLogic Main Business Overview
13.3.5 SomaLogic Latest Developments
13.4 AM Biotechnologies
13.4.1 AM Biotechnologies Company Information
13.4.2 AM Biotechnologies Aptamers Product Portfolios and Specifications
13.4.3 AM Biotechnologies Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AM Biotechnologies Main Business Overview
13.4.5 AM Biotechnologies Latest Developments
13.5 Aptamer Sciences
13.5.1 Aptamer Sciences Company Information
13.5.2 Aptamer Sciences Aptamers Product Portfolios and Specifications
13.5.3 Aptamer Sciences Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Aptamer Sciences Main Business Overview
13.5.5 Aptamer Sciences Latest Developments
13.6 Base Pair Biotechnologies
13.6.1 Base Pair Biotechnologies Company Information
13.6.2 Base Pair Biotechnologies Aptamers Product Portfolios and Specifications
13.6.3 Base Pair Biotechnologies Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Base Pair Biotechnologies Main Business Overview
13.6.5 Base Pair Biotechnologies Latest Developments
13.7 Aptamer Group
13.7.1 Aptamer Group Company Information
13.7.2 Aptamer Group Aptamers Product Portfolios and Specifications
13.7.3 Aptamer Group Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aptamer Group Main Business Overview
13.7.5 Aptamer Group Latest Developments
13.8 Aptagen
13.8.1 Aptagen Company Information
13.8.2 Aptagen Aptamers Product Portfolios and Specifications
13.8.3 Aptagen Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Aptagen Main Business Overview
13.8.5 Aptagen Latest Developments
13.9 Aptus Biotech
13.9.1 Aptus Biotech Company Information
13.9.2 Aptus Biotech Aptamers Product Portfolios and Specifications
13.9.3 Aptus Biotech Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aptus Biotech Main Business Overview
13.9.5 Aptus Biotech Latest Developments
13.10 NeoVentures Biotechnology
13.10.1 NeoVentures Biotechnology Company Information
13.10.2 NeoVentures Biotechnology Aptamers Product Portfolios and Specifications
13.10.3 NeoVentures Biotechnology Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 NeoVentures Biotechnology Main Business Overview
13.10.5 NeoVentures Biotechnology Latest Developments
13.11 Ray Biotech
13.11.1 Ray Biotech Company Information
13.11.2 Ray Biotech Aptamers Product Portfolios and Specifications
13.11.3 Ray Biotech Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Ray Biotech Main Business Overview
13.11.5 Ray Biotech Latest Developments
13.12 Vivonics
13.12.1 Vivonics Company Information
13.12.2 Vivonics Aptamers Product Portfolios and Specifications
13.12.3 Vivonics Aptamers Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Vivonics Main Business Overview
13.12.5 Vivonics Latest Developments
14 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-aptamers-market-growth-2025-2031

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare